When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Hepatite A

Last reviewed: 8 Feb 2026
Last updated: 20 May 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • febre
  • mal-estar
  • náuseas e vômitos
  • icterícia
  • hepatomegalia
  • dor no quadrante superior direito
  • fezes com cor de argila
Full details

Other diagnostic factors

  • fadiga
  • cefaleia
  • urina escura
  • prurido
  • artralgias e mialgias
  • tosse
  • diarreia
  • constipação
  • esplenomegalia
  • linfadenopatia cervical posterior
  • erupção cutânea evanescente
  • bradicardia
Full details

Risk factors

  • pessoas que moram em regiões endêmicas
  • viagens a regiões endêmicas
  • contato pessoal próximo com uma pessoa infectada
  • homens que fazem sexo com homens
  • surto conhecido de doenças transmitidas por alimentos
  • uso de drogas ilícitas
  • desabrigo
  • exposição ocupacional
Full details

Diagnostic tests

1st tests to order

  • transaminases séricas
  • bilirrubina sérica
  • ureia sanguínea
  • creatinina sérica
  • tempo de protrombina
  • anti-HAV imunoglobulina M (IgM)
Full details

Tests to consider

  • imunoglobulina G (IgG) contra vírus da hepatite A (HAV)
  • detecção do ácido ribonucleico (RNA) do vírus da hepatite A
Full details

Treatment algorithm

INITIAL

pessoas não vacinadas com exposição recente à hepatite A (<2 semanas)

ACUTE

hepatite A confirmada

Contributors

Authors

Doan Y Dao, MD

Assistant Professor of Medicine

Director, Center of Excellence for Liver Disease in Vietnam

Johns Hopkins School of Medicine

Department of Medicine

Division of GI and Hepatology

Baltimore MD

Disclosures

DYD receives grants from Roche Diagnostics International Ltd and Gilead Sciences.

Acknowledgements

Dr Doan Dao would like to gratefully acknowledge Dr Musaddiq Waheed and the late Dr Fida A. Khan, the previous contributors to this topic.

Disclosures

MW and FAK declared that they have no competing interests.

Peer reviewers

Howard J. Worman, MD

Professor of Medicine and Cell Biology

Columbia University College of Physicians and Surgeons

New York

NY

Disclosures

HJW declares that he has no competing interests.

Srikrishna Nagri, MD

Gastroenterologist

Dartmouth-Hitchcock Nashua

Nashua

NH

Disclosures

SN declares that he has no competing interests.

George Y. Wu, MD, PhD

Professor of Medicine

University of Connecticut Health Center

Farmington

CT

Disclosures

GYW is on the medical advisory boards of the following: Gilead Sciences, Bristol-Myers Squibb, AbbVie, and Intercept.

Kittichai Promrat, MD

Assistant Professor

Division of Gastroenterology

Department of Medicine

Brown University

RI

Divulgaciones

KP declares that he has no competing interests.

Pierre Van Damme, MD, PhD

Professor

Director of Vaccine & Infectious Disease Institute

University of Antwerp

Antwerp

Belgium

Divulgaciones

PVD has been and still is principal investigator of vaccine trials for several vaccine manufacturing companies, from which the university obtained and obtains research contracts and funds for conducting such vaccine trials.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Centers for Disease Control and Prevention. Hepatitis A. [internet publication].Texto completo

Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am. 2000 Sep;14(3):605-15. Resumen

Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020 Jul 3;69(5):1-38.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad